BCM
GEN

Bayesian Capital Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Bayesian Capital Management’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,832
Closed -$9K – 766
2020
Q2 		$9K Buy
+12,832
New +$10.3K ﹤0.01% 500

Other funds holding GEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Bayesian Capital Management's GEN Position: Q3 2020 in Review

Bayesian Capital Management sold out of Genesis Healthcare, Inc. (GEN) in Q3 2020, closing a stake of 12,832 shares — an estimated $9K sold.

Bayesian Capital Management first reported a position in GEN in Q2 2020 and held it in 1 quarter. The position peaked at $9K in Q2 2020. 55 funds tracked by Wall St. Rank hold GEN as of Q3 2020.

  • Bayesian Capital Management reported no remaining Genesis Healthcare, Inc. position as of Q3 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 12,832 Genesis Healthcare, Inc. shares in Q3 2020, an estimated $9K.
  • Bayesian Capital Management first reported a position in Genesis Healthcare, Inc. in Q2 2020 and held it in 1 quarter.
  • Bayesian Capital Management's Genesis Healthcare, Inc. position peaked at $9K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2020.

Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.